Nuvo Group Usa, Inc.

Nuvo Group USA, Inc. specializes in prenatal monitoring devices focused on fetal and maternal health. Their primary product category is foetal/maternal prenatal monitors, which are designed to track fetal heart rate and uterine activity during pregnancy. These devices are intended for clinical use in obstetric settings to help assess fetal well-being and monitor maternal contractions.

Nuvo Group USA, Inc. is based in the United States. This means their devices are developed and manufactured in compliance with U.S. medical device regulations, including those governing safety, performance, and quality standards. The company’s location also influences which regulatory pathways and databases their devices may be listed in, such as the FDA’s Unique Device Identifier (UDI) system.

Nuvo Group USA, Inc.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry helps ensure traceability and transparency in the medical device supply chain, allowing healthcare providers and regulators to identify and verify specific devices through their unique identifiers.

Nuvo Group USA, Inc.’s devices are classified as Class II under FDA regulations. This classification is based on the level of risk associated with the device. Class II devices generally require special controls in addition to general controls to ensure their safety and effectiveness, such as performance standards or post-market surveillance. The classification helps determine the regulatory pathway and oversight required for each device.